sulfinpyrazone has been researched along with Abnormalities, Drug-Induced in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anton, AH | 1 |
1 review available for sulfinpyrazone and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Drug-protein binding. IV. Modulation of binding. Increasing activity of sulfonamides with displacing agents: a review.
Topics: Abnormalities, Drug-Induced; Blood Proteins; Drug Synergism; Escherichia coli; Female; Fetus; Humans | 1973 |